Capital Planning Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-6,292
Closed -$327K 121
2018
Q4
$327K Sell
6,292
-13,227
-68% -$711K 0.12% 98
2018
Q3
$1.21M Buy
19,519
+4,187
+27% +$248K 0.39% 67
2018
Q2
$848K Sell
15,332
-14,118
-48% -$762K 0.38% 65
2018
Q1
$1.86M Sell
29,450
-5,916
-17% -$381K 0.66% 47
2017
Q4
$2.17M Sell
35,366
-4,395
-11% -$275K 0.76% 41
2017
Q3
$2.53M Sell
39,761
-4,956
-11% -$289K 0.99% 29
2017
Q2
$2.49M Sell
44,717
-3,580
-7% -$195K 1.1% 28
2017
Q1
$2.63M Sell
48,297
-2,000
-4% -$110K 1.3% 19
2016
Q4
$2.94M Sell
50,297
-11,644
-19% -$637K 1.57% 19
2016
Q3
$3.34M Buy
61,941
+13,020
+27% +$836K 1.78% 16
2016
Q2
$3.6M Sell
48,921
-3,605
-7% -$255K 2% 14
2016
Q1
$3.35M Sell
52,526
-668
-1% -$42.1K 1.62% 17
2015
Q4
$3.66M Buy
53,194
+8,389
+19% +$554K 2.13% 10
2015
Q3
$2.65M Buy
44,805
+1,145
+3% +$72.6K 1.74% 17
2015
Q2
$2.9M Buy
43,660
+10,015
+30% +$660K 1.7% 19
2015
Q1
$2.17M Buy
33,645
+5,980
+22% +$374K 1.51% 19
2014
Q4
$1.63M Buy
+27,665
New +$1.56M 1.42% 20

Other funds holding BMY

Capital Planning Advisors's BMY Position: Q1 2019 in Review

Capital Planning Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 6,292 shares — an estimated $327K sold.

Capital Planning Advisors first reported a position in BMY in Q4 2014 and held it in 17 quarters. The position peaked at $3.66M in Q4 2015. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Capital Planning Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Capital Planning Advisors sold 6,292 Bristol-Myers Squibb shares in Q1 2019, an estimated $327K.
  • Capital Planning Advisors first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 17 quarters.
  • Capital Planning Advisors's Bristol-Myers Squibb position peaked at $3.66M in Q4 2015.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Capital Planning Advisors's 13F filing for Q1 2019, filed 14 May 2019.